Sensitivity of scirrhous gastric cancer to 5-fluorouracil and the role of cancer cell-stromal fibroblast interaction

Oncology Reports

Volumn 12, Issue 1, 2004, Pages 85-90

  Nakajima, Koichi ^a   Okita, Yutaka ^b   Matsuda, Shozo ^c  

^a Public Chikusa Clinic   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Public Shiso General Hospital   (Japan)

Author keywords

Chemosensitivity; Fibroblast; Fluorouracil; Scirrhous gastric cancer; Tranilast

Indexed keywords

ANTHRANILIC ACID DERIVATIVE; ANTINEOPLASTIC ANTIMETABOLITE; CALCIUM CHANNEL BLOCKING AGENT; FLUOROURACIL; TRANILAST;

ARTICLE; CELL DIVISION; CELL LINE; COCULTURE; CYTOLOGY; DRUG EFFECT; FIBROBLAST; HUMAN; PATHOLOGY; STOMACH TUMOR; STROMA CELL; TUMOR CELL LINE;

ANTHRANILIC ACIDS; ANTIMETABOLITES, ANTINEOPLASTIC; CALCIUM CHANNEL BLOCKERS; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FIBROBLASTS; FLUOROURACIL; HUMANS; STOMACH NEOPLASMS; STROMAL CELLS;

EID: 21644472223     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.1.85     Document Type: Article

References (25)

1. Yoshida K, Yasui K, Ito H and Tahara E: Growth factors in progression of human esophageal and gastric carcinoma. Exp Pathol 40: 291-300, 1990.
2. Yokota T, Teshima S, Saito T, Kikuchi S, Kunii Y and Yamauchi H: Borrmann's type IV gastric cancer: clinicopathologic analysis. Can J Surg 42: 371-376, 1999. (Pubitemid 29479814)
3. Kitamura K, Beppu R, Anai H, Ikejiri K, Yakabe S, Sugimachi K and Saku M: Clinicopathologic study of patients with Borrmann type IV gastric carcinoma. J Surg Oncol 58: 112-117, 1995.
4. Maeda O, Iwase H, Mamiya N, Nakamura M, Mizuno T, Nishio Y, Ando T, Ina K and Kusugami K: Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin. Intern Med 39: 239-244, 2000. (Pubitemid 30204917)
5. Takahashi S, Kinoshita T, Konishi M, Nakagouri T, Inoue K, Ono M, Sugitou M, Ohtsu A, Boku N and Yoshida S: Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer. Gastric Cancer 4: 192-197, 2001. (Pubitemid 34201779)
6. Suga S, Iwase H, Shimada M, Nishio Y, Ichihara T, Ichihara S, Kusugami K and Saito H: Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin. Intern Med 35: 930-936, 1996. (Pubitemid 27088981)
7. Tahara E: Cancer-stromal interaction through growth factor/ cytokine networks implicated in growth of stomach cancer. Princess Takamatsu Symp 24: 187-194, 1994.
8. Azuma H, Banno K and Yoshimura T: Pharmacological properties of N-(3′, 4′-dimethoxycinnamoyl) anthranilic acid (N-5′), a new anti-atopic agent. Br J Pharmacol 58: 483-488, 1976.
9. Isaji M, Aruga N, Naito J and Miyata H: Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro. Life Sci 55: 287-292, 1994.
10. Fukuyama J, Ichikawa K, Miyazawa K, Hamano S, Shibata N and Ujiie A: Tranilast suppresses intimal hyperplasia in the balloon injury model and cuff treatment model in rabbits. Jpn J Pharmacol 70: 321-327, 1996.
11. Sekiguchi M, Sakakibara K and Fujii G: Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48: 61-68, 1978. (Pubitemid 8328492)
12. Namba M, Nishitani K, Hyodoh F, Fukushima F and Kimoto T: Neoplastic transformation of human diploid fibroblasts (KMST-6) by treatment with 60Co gamma rays. Int J Cancer 35: 275-280, 1985. (Pubitemid 16179973)
13. Tanigawa N, Kitaoka A, Yamakawa M, Tanisaka K, Kobayashi H: In vitro chemosensitivity testing of human tumours by collagen gel droplet culture and image analysis. Anticancer Res 16: 1925-1930, 1996. (Pubitemid 26270704)
14. Kobayashi H, Higashiyama M, Minamigawa K, Tanisaka K, Takano T, Yokouchi H, Kodama K and Hata T: Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification. Jpn J Cancer Res 92: 203-210, 2001. (Pubitemid 32241776)
15. Yasuda H, Takada T, Wada K, Amano H, Isaka T, Yoshida M, Uchida T and Toyota N: A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility. J Hepatobiliary Pancreat Surg 5: 261-268, 1998. (Pubitemid 128662591)
16. Murakami N, Koufuji K and Shirouzu K: Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer. Int Surg 86: 151-157, 2001. (Pubitemid 33594361)
17. Inoue T, Chung YS, Yashiro M, Nishimura S, Hasuma T, Otani S and Sowa M: Transforming growth factor-β and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res 88: 152-159, 1997. (Pubitemid 27129642)
18. Koyama T, Yashiro M, Inoue T, Nishimura S and Hirakawa K-Chung YS: TGF-β1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells. Int J Oncol 16: 355-362, 2000.
19. Beck A, Etienne MC, Cheradame S, Fischel JL, Formento P, Renee N and Milano G: A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur J Cancer 30A: 1517-1522, 1994. (Pubitemid 24343014)
20. Murahashi K, Yashiro M, Inoue T, Nishimura S, Matsuoka T, Sawada T, Sowa M and Hirakawa K-YS Chung: Tranilast and cisplatin as an experimental combination therapy for scirrhous gastric cancer. Int J Oncol 13: 1235-1240, 1998. (Pubitemid 28551550)
21. Platten M, Wild-Bode C, Wick W, Leitlein J, Dichgans J and Weller M: N- (3′, 4′-dimethoxycinnamoyl)-anthranilic acid (tranilast) inhibits transforming growth factor-β release and reduces migration and invasiveness of human malignant glioma cells. Int J Cancer 93: 53-61, 2001.
22. Nie L, Oishi Y, Doi I, Shibata H and Kojima I: Inhibition of proliferation of MCF-7 breast cancer cells by a blocker of Ca (2+)-permeable channel. Cell Calcium 22: 75-82, 1997. (Pubitemid 27390421)
23. Hiroi M, Onda M, Uchida E and Aimoto T: Anti-tumor effect of N- (3′, 4′-dimethoxycinnamoyl)-anthranilic acid (tranilast) on experimental pancreatic cancer. Nippon Ika Daigaku Zasshi 69: 224-234, 2002. (Pubitemid 34717634)
24. Yatsunami J, Aoki S, Fukuno Y, Kikuchi Y, Kawashima M and Hayashi SI: Antiangiogenic and antitumor effects of tranilast on mouse lung carcinoma cells. Int J Oncol 17: 1151-1156, 2000.
25. Nakada T, Ishikawa S, Sakamota M, Katayama T, Igarashi T, Mizumura Y, Koizumi F, Shigematsu H and Fukuda T: N- (3′, 4′-dimethoxycinnamoyl) anthranilic acid, an antiallergic compound, induced eosinophilic cystitis. Urol Int 41: 457-464, 1986. (Pubitemid 17223741)